Statin use and outcome among breast cancer patients treated with neoadjuvant systemic chemotherapy

被引：0
|
作者：
Gregor, M. Chavez-Mac [1 ]
Lei, X. [1 ]
Litton, J. K. [1 ]
Melhem-Bertrand, A. [1 ]
Giordano, S. H. [1 ]
Masuda, H. [1 ]
Ueno, N. [1 ]
Gabriel, H. N. [1 ]
Valero, V. [1 ]
机构：
[1] UT MD Anderson Canc Ctr, Houston, TX USA
来源：
CANCER RESEARCH | 2013年 / 73卷
关键词：
D O I：
10.1158/0008-5472.SABCS13-P3-12-06
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-12-06
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Axillary staging and management of cN + breast cancer patients treated with neoadjuvant chemotherapy: results of a survey among breast cancer surgeons in Spain
    Paula Munoz
    Sara Corral
    Fernando Martínez-Regueira
    Alejandro Paz
    Vicente Muñoz-Madero
    Antonio Mena
    Jacobo Cabañas
    Sonia Rivas
    Clinical and Translational Oncology, 2023, 25 : 1463 - 1471
  • [22] The Relevance of Breast Cancer Subtypes in the Outcome of Neoadjuvant Chemotherapy
    Straver, M. E.
    Rutgers, E. J. Th.
    Rodenhuis, S.
    Linn, S. C.
    Loo, C. E.
    Wesseling, J.
    Russell, N. S.
    Oldenburg, H. S. A.
    Antonini, N.
    Peeters, M. T. F. D. Vrancken
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (09) : 2411 - 2418
  • [23] The Relevance of Breast Cancer Subtypes in the Outcome of Neoadjuvant Chemotherapy
    M. E. Straver
    E. J. Th. Rutgers
    S. Rodenhuis
    S. C. Linn
    C. E. Loo
    J. Wesseling
    N. S. Russell
    H. S. A. Oldenburg
    N. Antonini
    M. T. F. D. Vrancken Peeters
    Annals of Surgical Oncology, 2010, 17 : 2411 - 2418
  • [24] Sentinel Lymph Node Biopsy in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy
    Pecha, Vaclav
    Kolarik, Dusan
    Kozevnikova, Renata
    Hovorkova, Karolina
    Hrabetova, Petruse
    Halaska, Michael
    Sottner, Oldrich
    Trnkova, Marketa
    Petruzelka, Lubos
    Kolarova, Hana
    CANCER, 2011, 117 (20) : 4606 - 4616
  • [25] Validation of a novel staging system for breast cancer patients treated with neoadjuvant chemotherapy
    Mittendorf, E. A.
    Tucker, S. L.
    Jeruss, J. S.
    Gonzalez-Angulo, A. M.
    Buchholz, T. A.
    Sahin, A. A.
    Cormier, J. N.
    Buzdar, A. U.
    Hortobagyi, G. N.
    Hunt, K. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [26] Nomogram predicting clinical outcomes in breast cancer patients treated with neoadjuvant chemotherapy
    Keam, Bhumsuk
    Im, Seock-Ah
    Park, Sohee
    Nam, Byung-Ho
    Han, Sae-Won
    Oh, Do-Youn
    Kim, Jee Hyun
    Lee, Se-Hoon
    Han, Wonshik
    Kim, Dong-Wan
    Kim, Tae-You
    Park, In Ae
    Noh, Dong-Young
    Heo, Dae Seog
    Bang, Yung-Jue
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2011, 137 (09) : 1301 - 1308
  • [27] Prognostic Factors in Triple Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
    Wada, N.
    Yoneyama, K.
    Yamauchi, C.
    Fujii, S.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S140 - S140
  • [28] Sentinel Lymph Node Biopsy in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
    Kolarik, D.
    Pecha, V.
    Sykorova, J.
    Kaus, K.
    Kozevnikova, R.
    Hovorkova, K.
    Hrabetova, P.
    Sottner, O.
    Trnkova, M.
    Kolarova, H.
    CANCER RESEARCH, 2010, 70
  • [29] The role of IRAK1 in breast cancer patients treated with neoadjuvant chemotherapy
    Yang, Muwen
    Qin, Xingsong
    Qin, Guangyuan
    Zheng, Xinyu
    ONCOTARGETS AND THERAPY, 2019, 12 : 2171 - 2180
  • [30] Predictive value of microenvironment for progression in breast cancer patients treated with neoadjuvant chemotherapy
    Goto, Wataru
    Kashiwagi, Shinichiro
    Asano, Yuka
    Takada, Koji
    Takahashi, Katsuyuki
    Noda, Satoru
    Takashima, Tsutomu
    Onoda, Naoyoshi
    Tomita, Shuhei
    Hirakawa, Kosei
    Ohira, Masaichi
    CANCER SCIENCE, 2018, 109 : 123 - 123
12345